Crescent Grove Advisors, LLC Danaher Corp Transaction History

Crescent Grove Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 12, 2023	BUY	$241.42 - $282.29 $12,071 - $14,114	50 Added 4.06%	1,281 $0
Q3 2022 Nov 08, 2022	BUY	$247.06 - $1507.4 $12,353 - $75,370	50 Added 4.23%	1,231 $318,000
Q2 2022 Jul 20, 2022	SELL	$237.11 - $299.66 $15,412 - $19,477	-65 Reduced 5.22%	1,181 $300,000
Q1 2022 May 04, 2022	BUY	$257.27 - $315.76 $65,346 - $80,203	254 Added 25.6%	1,246 $366,000
Q4 2021 Jan 24, 2022	BUY	$292.08 - $329.01 $3,212 - $3,619	11 Added 1.12%	992 $327,000
Q2 2021 Jul 26, 2021	BUY	$225.08 - $271.69 $220,803 - $266,527	981 New	981 $263,000

2,508

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Crescent Grove Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Crescent Grove Advisors, LLC with notifications on news.